Delivery Order SPE2DE22D0008-SPE2D626F7079
Award Date 10/30/25
Potential Completion Date 1/7/26
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded Alba Bioscience, Inc. a $9,500 delivery order on October 30, 2025, for an ALBACYTE Antibody ID Panel (10-Cell) with a completion date of January 7, 2026. This firm fixed-price delivery order represents a competitive procurement without set-aside designation, leveraging Alba Bioscience's specialized capabilities in immunohematology reagents and blood banking diagnostics. Alba Bioscience, a Chicago-based subsidiary of...
- Alba Bioscience, Inc. was awarded a delivery order valued at $1,123.00 by the Medical Supply Chain division of the Defense Department on July 29, 2025, with an ultimate completion date of August 1, 2025. The contract, identified as 4568920078, covers the supply of ALBACLONE Anti-A antibodies, specialized reagents used in blood banking and immunohematology testing. This non-set-aside award was issued under a firm fixed-price arrangement, with performance to be completed in Chicago, Illinois. Alba...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,080 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-E monoclonal antibodies under a firm fixed price contract. The award, issued on October 30, 2025, with an ultimate completion date of November 4, 2025, represents a competitive procurement with no set-aside designation. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and...
- Alba Bioscience, Inc. received a $2,030 firm fixed-price delivery order from the Department of Defense's Medical Supply Chain on June 5, 2025, for the ALBACYTE Antibody ID Panel (16-Cell). The contract, which carries an ultimate completion date of August 11, 2025, was awarded without a set-aside designation, reflecting Alba Bioscience's competitive standing as a supplier of specialized in vitro diagnostic products. Performance will take place in Chicago, Illinois, where the vendor maintains...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order contract to Alba Bioscience, Inc. for ALBACLONE anti-FYB antibody screening products. The contract, valued at $12,875 with a firm fixed price structure, was executed on September 4, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside award represents a continuation of Alba Bioscience's established role as a critical supplier of specialized in vitro diagnostic...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc. The contract is for the delivery of ALBACYTE antibody identification panels, which are in vitro diagnostic products used in blood banking operations across various government agencies, including the Department of Veterans Affairs (VA), Defense Health Agency (DHA), and National Institutes of Health (NIH). The contract is a Delivery Order with a Firm...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain division to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $10,683.00, is for the delivery of ALBACYTE antibody identification panels and is a firm fixed-price agreement with a completion date...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency's Medical Supply Chain (DLA Troop Support) to Alba Bioscience, Inc., a foreign-owned for-profit organization. The $7,590.00 contract is for the delivery of 4564147584 ! ALBACYTE ANTIBODY ID PANEL (10-CELL) by June 5, 2024. The award does not have a set-aside designation, likely due to the specialized nature of the medical products. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc., a leading...
- This federal contract award is for the delivery of ALBACYTE antibody screening (3-cell) products to the Defense Logistics Agency (DLA). The contract, valued at $1,281.00, was awarded to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other biomedical products to various federal agencies, including the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS). The...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit medical supply company, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of ALBACYTE antibody screening tests, with a ceiling value of $2,520.00 and a period of performance through April 15, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc. and is a leading supplier of...